Anonymous, non-contactable employee v Astellas

False response and further failure to provide accurate information

Corrective statement

Astellas Pharma Europe Ltd was required to provide UK delegates who attended its meeting on 27/28 February 2014 with a corrective statement. The meeting (Case AUTH/2747/1/15​)​ was ruled in breach of the ABPI Code of Practice for the Pharmaceutical Industry and the corrective statement was sent on 1 July 2015.

Following a second complaint (Case AUTH/2780/7/15), the Code of Practice Panel ruled that Astellas Pharma Europe and Astellas UK had provided the Panel and the Appeal Board with false and incomplete information regarding the selection criteria for attendees at the meeting. High standards had not been maintained and this had brought discredit upon, and reduced confidence in, the pharmaceutical industry. As a result Astellas Pharma Europe and Astellas UK have been required to issue this further corrective statement and to circulate a copy of the published report for Case AUTH/2780/7/15 which contains full details and is enclosed.

Details of these cases (Case AUTH/2747/1/15​ and Case AUTH/2780/7/15​) are also available on the PMCPA website (www.pmcpa.org.uk).
* * * * * *
Astellas Pharma Europe and Astellas UK sent copies of the case report and the company's corrective statement to all UK attendees at the meeting. The materials were sent on 4 January 2016.

Date posted 7 January 2016